UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 2.451

Sortiert nach

A switch in regulatory T cells through farm exposure during immune maturation in childhood

Allergy (Copenhagen), 2017-04, Vol.72 (4), p.604-615

2017

Volltextzugriff (PDF)

Farm exposures are associated with lower percentage of circulating myeloid dendritic cell subtype 2 at age 6

Allergy (Copenhagen), 2015-10, Vol.70 (10), p.1278-1287

2015

Volltextzugriff (PDF)

Molecular imaging as a tool to investigate heterogeneity of advanced HER2-positive breast cancer and to predict patient outcome under trastuzumab emtansine (T-DM1): the ZEPHIR trial

Annals of oncology, 2016-04, Vol.27 (4), p.619-624

2016

Volltextzugriff (PDF)

Circulating Dendritic Cells, Farm Exposure and Asthma at Early Age

Scandinavian journal of immunology, 2016-01, Vol.83 (1), p.18-25

2016

Volltextzugriff (PDF)

Glycogen synthase 1 targeting reveals a metabolic vulnerability in triple-negative breast cancer

Journal of experimental & clinical cancer research, 2023-06, Vol.42 (1), p.143-143, Article 143

2023

Volltextzugriff (PDF)

Distress, problems, referral wish, and supportive health care use in breast cancer survivors beyond the first year after chemotherapy completion

Supportive care in cancer, 2020-07, Vol.28 (7), p.3023-3032

2020

Volltextzugriff (PDF)

Correction: Glycogen synthase 1 targeting reveals a metabolic vulnerability in triple-negative breast cancer

Journal of experimental & clinical cancer research, 2023-08, Vol.42 (1), p.1-220, Article 220

2023

Volltextzugriff (PDF)

Axillary staging for breast cancer during pregnancy: feasibility and safety of sentinel lymph node biopsy

Breast cancer research and treatment, 2018-04, Vol.168 (2), p.551-557

2018

Volltextzugriff (PDF)

Zirconium-89 (89Zr)-labeled bispecific T-cell engager (BiTE®) AMG 211 PET imaging to determine AMG 211 biodistribution in patients with gastrointestinal (GI) adenocarcinomas

Annals of oncology, 2018-10, Vol.29 Suppl 8, p.viii139

2018

Volltextzugriff (PDF)

High-dose chemotherapy (HDCT) with hematopoietic stem cell transplantation (HSCT) in high-risk breast cancer (BC) patients with ≥4 involved axillary lymph nodes (ALN): 20-year follow-up of a randomized phase 3 study

Annals of oncology, 2018-10, Vol.29, p.viii59-viii59

2018

Volltextzugriff (PDF)

Targeting breast cancer through its microenvironment: current status of preclinical and clinical research in finding relevant targets

Pharmacology & therapeutics (Oxford), 2015-03, Vol.147, p.63-79

2015

Volltextzugriff (PDF)

Molecular imaging of breast cancer

Breast (Edinburgh), 2009-10, Vol.18, p.S66-S73

2009

Volltextzugriff (PDF)

Impact of primary local treatment on the development of distant metastases or death through locoregional recurrence in young breast cancer patients

Breast cancer research and treatment, 2013-08, Vol.140 (3), p.577-585

2013

Volltextzugriff (PDF)

Performance of BRCA1/2 mutation prediction models in male breast cancer patients

Clinical genetics, 2018-01, Vol.93 (1), p.52-59

2018

Volltextzugriff (PDF)

Enhanced pulmonary uptake on 18F-FES-PET/CT scans after irradiation of the thoracic area: related to fibrosis?

EJNMMI research, 2019-08, Vol.9 (1), p.1-7, Article 82

2019

Volltextzugriff (PDF)

An in vitro model for purging of tumour cells from ovarian tissue

Human reproduction (Oxford), 2004-05, Vol.19 (5), p.1069-1075

2004

Volltextzugriff (PDF)

Severe disabling tendinopathy caused by anastrazole

Rheumatology (Oxford, England), 2007-10, Vol.46 (10), p.1619-1621

2007

Volltextzugriff (PDF)

Telomere length in breast cancer patients before and after chemotherapy with or without stem cell transplantation

British journal of cancer, 2001-05, Vol.84 (10), p.1348-1353

2001

Volltextzugriff (PDF)

Evaluation of FES (16α-[18F]-fluoro-17β-estradiol) PET for (re)staging of patients with clinical (locally) advanced or locoregional recurrent estrogen receptor positive breast cancer

European journal of cancer (1990), 2020-10, Vol.138, p.S88-S88

2020

Volltextzugriff (PDF)

89Zr-trastuzumab PET supports clinical decision making in breast cancer patients, when HER2 status cannot be determined by standard work up

European journal of nuclear medicine and molecular imaging, 2018-12, Vol.45 (13), p.2300-2306

2018

Volltextzugriff (PDF)

Pathological characterisation of male breast cancer: Results of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program

European journal of cancer (1990), 2017-09, Vol.82, p.219-227

2017

Volltextzugriff (PDF)

Prevention of febrile leucopenia after chemotherapy in high-risk breast cancer patients : no significant difference between granulocyte-colony stimulating growth factor or ciprofloxacin plus amphotericin B

Journal of antimicrobial chemotherapy, 1999-05, Vol.43 (5), p.741-743

1999

Volltextzugriff (PDF)

Male breast cancer precursor lesions: analysis of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program

Modern pathology, 2017-04, Vol.30 (4), p.509-518

2017

Volltextzugriff (PDF)

Use of biomarkers and imaging to evaluate the treatment effect of AUY922, an HSP90 inhibitor, in patients with HER2+ or ER+ metastatic breast cancer

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.e11024-e11024

2011

Volltextzugriff (PDF)

Tributyrin enhances the cytotoxic activity of interleukin-2 interleukin-12 stimulated human natural killer cells against LS 174T colon cancer cells in vitro

Cancer Immunology, Immunotherapy, 2001-04, Vol.50 (2), p.69-76

2001

Volltextzugriff (PDF)

1 – 25 von 2.451

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(2.094)
Mit Volltextzugriff
(2.213)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

6 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Ingenta
(1.234)
EZB Electronic Journals Library
(1.040)
MEDLINE
(804)
Elsevier ScienceDirect Journals Complete
(656)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(554)
IngentaConnect Journals
(514)
Ovid SocietyJournals and Single Titles
(494)
Springer journals
(413)
NUS Single-Journal Subscriptions
(359)
Wiley-Blackwell Journals
(296)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(287)
Wiley Online Library
(235)
Ebook Central Perpetual and DDA
(110)
eBooks on EBSCOhost
(104)
Oxford journals
(103)
American Physical Society
(69)
Oxford Journals 2020 Medicine
(64)
Nature_系列刊
(61)
PROLA
(59)
JSTOR
(56)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

A switch in regulatory T cells through farm exposure during immune maturation in childhood

Farm exposures are associated with lower percentage of circulating myeloid dendritic cell subtype 2 at age 6

Molecular imaging as a tool to investigate heterogeneity of advanced HER2-positive breast cancer and to predict patient outcome under trastuzumab emtansine (T-DM1): the ZEPHIR trial

Circulating Dendritic Cells, Farm Exposure and Asthma at Early Age

Glycogen synthase 1 targeting reveals a metabolic vulnerability in triple-negative breast cancer

Distress, problems, referral wish, and supportive health care use in breast cancer survivors beyond the first year after chemotherapy completion

Correction: Glycogen synthase 1 targeting reveals a metabolic vulnerability in triple-negative breast cancer

Axillary staging for breast cancer during pregnancy: feasibility and safety of sentinel lymph node biopsy

Zirconium-89 (89Zr)-labeled bispecific T-cell engager (BiTE®) AMG 211 PET imaging to determine AMG 211 biodistribution in patients with gastrointestinal (GI) adenocarcinomas

High-dose chemotherapy (HDCT) with hematopoietic stem cell transplantation (HSCT) in high-risk breast cancer (BC) patients with ≥4 involved axillary lymph nodes (ALN): 20-year follow-up of a randomized phase 3 study

Targeting breast cancer through its microenvironment: current status of preclinical and clinical research in finding relevant targets

Molecular imaging of breast cancer

Impact of primary local treatment on the development of distant metastases or death through locoregional recurrence in young breast cancer patients

Performance of BRCA1/2 mutation prediction models in male breast cancer patients

Enhanced pulmonary uptake on 18F-FES-PET/CT scans after irradiation of the thoracic area: related to fibrosis?

An in vitro model for purging of tumour cells from ovarian tissue

Severe disabling tendinopathy caused by anastrazole

Telomere length in breast cancer patients before and after chemotherapy with or without stem cell transplantation

Evaluation of FES (16α-[18F]-fluoro-17β-estradiol) PET for (re)staging of patients with clinical (locally) advanced or locoregional recurrent estrogen receptor positive breast cancer

89Zr-trastuzumab PET supports clinical decision making in breast cancer patients, when HER2 status cannot be determined by standard work up

Pathological characterisation of male breast cancer: Results of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program

Prevention of febrile leucopenia after chemotherapy in high-risk breast cancer patients : no significant difference between granulocyte-colony stimulating growth factor or ciprofloxacin plus amphotericin B

Male breast cancer precursor lesions: analysis of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program

Use of biomarkers and imaging to evaluate the treatment effect of AUY922, an HSP90 inhibitor, in patients with HER2+ or ER+ metastatic breast cancer

Tributyrin enhances the cytotoxic activity of interleukin-2 interleukin-12 stimulated human natural killer cells against LS 174T colon cancer cells in vitro

Suchergebnisse filtern